MA Crowther, W Ageno, D Garcia - Journal of Vascular Surgery, 2009 - Elsevier The authors hypothesized patients with INRs >4.5 treated with vitamin K therapy would have
less bleeding complications than those in which warfarin therapy was merely withheld until the
INR returned to therapeutic levels. They tested their hypothesis by performing a ... Cited by 6 - Related articles - All 15 versions
M Rondina - Annals of internal medicine, 2009 - ncbi.nlm.nih.gov 1: Ann Intern Med. 2009 Jun 16;150(12):JC6-9. Comment on: Ann Intern Med. 2009 Mar
3;150(5):293-300. ACP Journal Club. Oral vitamin K did not reduce bleeding in patients
with excessive anticoagulation after receiving warfarin. Rondina M. ... Cited by 1 - Related articles
- ►grupocaht.com [PDF] A Tripodi, A van den Besselaar - Semin Thromb Hemost, 2009 - thieme-connect.com The treatment of choice for acute venous thromboembolism is anticoagulant therapy with
fast-acting drugs (unfractionated or low-molecular-weight heparin or fondaparinux) aimed at
preventing thrombus extension, followed by extended prophylaxis with vitamin K ... Cited by 1 - Related articles - All 2 versions
J Yang, N Paredes, AKC Chan - Hämostaseologie, 2009 - schattauer.de Summary Antithrombotic therapy has recently become more frequent for the treatment of venous
thromboembolism (VTE) in the paediatric population. This can be explained by the in- creased
awareness of morbidities and mortalities of VTE in children, as well as the improved ... Cited by 1 - Related articles - All 3 versions
T Wilke, S Tesch, A Scholz, T Kohlmann, A … - J Thromb …, 2009 - ipam.hs-wismar.de Summary. Background and objectives:Due to the complexity of heparin-induced thrombocytopenia
(HIT), currently available cost analyses are rough estimates. The objectives of this study were
quantification of costs involved in HIT and identification of main cost drivers based on a ... Cited by 1 - Related articles - View as HTML - All 6 versions
B Abrahamsen, P Eiken, R Eastell, DH … - The New England …, 2009 - nejm.highwire.org Using data from national registers (1995 through 2005), we individually matched 13,678 patients
with fracture who had filled more than one prescription for any oral bisphosphonate (62% for
alendronate, 36% for etidronate, and 2% for ibandronate, risedronate, or clodronate) with ... Cited by 1 - Related articles - All 3 versions
M Levi, K Hovingh - Thrombosis and haemostasis, 2008 - ncbi.nlm.nih.gov 1: Thromb Haemost. 2008 Dec;100(6):1047-51. Bleeding complications in patients
on anticoagulants who would have been disqualified for clinical trials. Levi M,
Hovingh K. Dept. Internal Medicine, Academic Medical Centre ... Cited by 1 - Related articles
AC Good, S Henz - Thrombosis Research, 2007 - Elsevier In many countries phenprocoumon is predominantly used for oral anticoagulation. Given its long
half-life of 110–130 h [1] an initial loading-dose is generally applied [2]. A high loading-dose
is helpful to rapidly reach a therapeutic steady-state concentration but may be associated ... Cited by 1 - Related articles - All 8 versions
DH Solomon, A Patrick, MA Brookhart - The New England journal of …, 2009 - ncbi.nlm.nih.gov 1: N Engl J Med. 2009 Apr 23;360(17):1789-90; author reply 1791-2. Comment on:
N Engl J Med. 2009 Jan 1;360(1):89-90. More on reports of esophageal cancer with
oral bisphosphonate use. Solomon DH, Patrick A, Brookhart MA. ... Cited by 1 - Related articles
DSM Buist, ML Anderson, SD Reed, EJA Bowles, … - Ann Intern Med, 2009 - Am Coll Physicians Background: Without population-based evidence, some clinicians recommend short-term suspension
of hormone therapy to improve the performance of mammography. Hormone therapy increases
breast density, and abnormal screening mammograms are more common among women ... Cited by 2 - Related articles - All 4 versions
